Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 21, 2012. The report details a specific corporate action regarding the repurchase of the company's own shares in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 750,000 Ordinary Shares of 25 pence each.
- Transaction Date: August 21, 2012.
- Price Range: Highest price paid was 1,479 pence per share; lowest price paid was 1,462.5 pence per share.
Material Changes and Treasury Holdings
Following the repurchase, the company's treasury holdings have increased. The filing reports the following status regarding share capital and voting rights:
- Treasury Shares Held: 491,032,927 shares (8.97% of total issued share capital).
- Treasury Shares (Including Unsettled): 493,258,927 shares (9.90% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,980,968,621 shares.
The company intends to hold the newly purchased shares in Treasury.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is a compliance disclosure confirming the share buyback and updating the share count for regulatory transparency under the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (491,032,927) against the company's latest annual report.
- Confirm the total issued share capital excluding treasury shares (4,980,968,621) for accurate voting rights calculations.
- Review the price paid per share (1,462.5 to 1,479 pence) to assess the cost of capital return relative to market prices on August 21, 2012.
- Note that this filing does not contain operational or financial performance data; refer to Form 20-F for full financial results.